Back to Faculty
Faculty

Suzanne Schindler

MD, PHD
Professor of Neurology
Washington University

Professor Suzanne E. Schindler, M.D., Ph.D., is a clinical neurologist and neuroscientist dedicated to advancing the diagnosis and treatment of Alzheimer’s disease. She cares for patients with memory concerns at the Washington University Memory Diagnostic Center, where she also coordinates the collection and analysis of real-world data on Alzheimer’s biomarkers and amyloid-targeted therapies. Dr. Schindler leads the Fluid Biomarker Core of the Knight Alzheimer’s Disease Research Center and has facilitated numerous collaborative studies, including those that developed and validated some of the first clinically available blood tests for Alzheimer’s disease pathology. She has evaluated the generalizability of AD biomarkers across diverse groups, led head-to-head comparisons of Alzheimer’s blood tests, studied the timing of key events in the disease, and co-led the creation of consensus recommendations for the performance of clinical Alzheimer’s blood tests. An active educator, she trains clinicians on integrating Alzheimer’s biomarkers into their evaluation of patients with cognitive impairment.

2026 Sessions

Biomarkers in Alzheimer’s Disease: CSF, PET and Blood-Based Testing

Biomarkers are transforming the diagnosis and management of Alzheimer’s disease. This session provides a comparative overview of cerebrospinal fluid (CSF), PET imaging, and emerging blood-based biomarkers, highlighting their clinical utility, limitations, and future applications.

Presenter

Saturday, December 05 10:30–11:30 AM
Room Windsong 1-4
Faculty

Suzanne Schindler

MD, PHD
Professor of Neurology
Washington University

Professor Suzanne E. Schindler, M.D., Ph.D., is a clinical neurologist and neuroscientist dedicated to advancing the diagnosis and treatment of Alzheimer’s disease. She cares for patients with memory concerns at the Washington University Memory Diagnostic Center, where she also coordinates the collection and analysis of real-world data on Alzheimer’s biomarkers and amyloid-targeted therapies. Dr. Schindler leads the Fluid Biomarker Core of the Knight Alzheimer’s Disease Research Center and has facilitated numerous collaborative studies, including those that developed and validated some of the first clinically available blood tests for Alzheimer’s disease pathology. She has evaluated the generalizability of AD biomarkers across diverse groups, led head-to-head comparisons of Alzheimer’s blood tests, studied the timing of key events in the disease, and co-led the creation of consensus recommendations for the performance of clinical Alzheimer’s blood tests. An active educator, she trains clinicians on integrating Alzheimer’s biomarkers into their evaluation of patients with cognitive impairment.
Back to top